4 Results

People

  1. Fong
    Fong
  2. D'Angelica
    D'Angelica
  3. DeMatteo
    DeMatteo
  4. Jarnagin
    Jarnagin
  5. Capanu
    Capanu
  6. Gonen
    Gonen
  7. Haviland
    Haviland
  8. Kemeny
    Kemeny
  9. Allen
    Allen
  10. Banerjee
    Banerjee

Groups

  1. Biostatistics Service (4)
  2. Center for Pancreatic Cancer Research (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. Gastrointestinal Oncology Service (4)
  6. Solid Tumor Oncology Division (4)
  7. Surgery (4)
  8. Body Imaging Service (1)
  9. Colorectal Surgery (1)
  10. GME, Neurology (1)
  1. "Department of Medicine"
  2. "Epidemiology and Biostatistics"
  3. "cancer growth"
  4. "Yuman Fong"
Formats
  1. Journal Article (4)
Groups
  1. Biostatistics Service (4)
  2. Center for Pancreatic Cancer Research (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. Gastrointestinal Oncology Service (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Nancy Kemeny (4)
  2. Yuman Fong (4)
  3. Michael D'Angelica (3)
  4. Ronald DeMatteo (3)
  5. William Jarnagin (3)
  6. Dana Haviland (2)

More People

Years
  1. 2011 (1)
  2. 2009 (2)
  3. 2003 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of Oncology (1)
  3. Annals of Surgical Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Oxford University Press (1)
  3. Springer (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer
    Journal Article

    Kemeny, N. E.; Jarnagin, W. R.; Capanu, M.; Fong, Y.; Gewirtz, A. N.; DeMatteo, R. P.; D'Angelica, M. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Regional chemotherapy for unresectable primary liver cancer: Results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
    Journal Article

    Jarnagin, W. R.; Schwartz, L. H.; Gultekin, D. H.; Gonen, M.; Haviland, D.; Shia, J.; D'Angelica, M.; Fong, Y.; DeMatteo, R.; Tse, A.; more...
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases
    Journal Article

    Gallagher, D. J.; Zheng, J.; Capanu, M.; Haviland, D.; Paty, P.; DeMatteo, R. P.; D'Angelica, M.; Fong, Y.; Jarnagin, W. R.; Allen, P. J.; more...
    Annals of Surgical Oncology (2009)

    Fulltext@MSK | Save
  • Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer
    Journal Article

    Gonen, M.; Hummer, A.; Zervoudakis, A.; Sullivan, D.; Fong, Y.; Banerjee, D.; Klimstra, D.; Cordon-Cardo, C.; Bertino, J.; Kemeny, N.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save